These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 36278349)
1. Synaptic Proteins as Fluid Biomarkers in Alzheimer's Disease: A Systematic Review and Meta-Analysis. Roveta F; Cermelli A; Boschi S; Ferrandes F; Grassini A; Marcinnò A; Spina M; Rubino E; Borsello T; Vercelli A; Rainero I J Alzheimers Dis; 2022; 90(4):1381-1393. PubMed ID: 36278349 [TBL] [Abstract][Full Text] [Related]
2. Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer's disease. Kivisäkk P; Carlyle BC; Sweeney T; Quinn JP; Ramirez CE; Trombetta BA; Mendes M; Brock M; Rubel C; Czerkowicz J; Graham D; Arnold SE Alzheimers Res Ther; 2022 Apr; 14(1):58. PubMed ID: 35461266 [TBL] [Abstract][Full Text] [Related]
3. Plasma neuregulin 1 as a synaptic biomarker in Alzheimer's disease: a discovery cohort study. Vrillon A; Mouton-Liger F; Martinet M; Cognat E; Hourregue C; Dumurgier J; Bouaziz-Amar E; Brinkmalm A; Blennow K; Zetterberg H; Hugon J; Paquet C Alzheimers Res Ther; 2022 May; 14(1):71. PubMed ID: 35606871 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer's disease continuum. Goossens J; Cervantes González A; Dewit N; Lidón L; Fortea J; Alcolea D; Lleó A; Belbin O; Vanmechelen E Alzheimers Res Ther; 2023 Oct; 15(1):186. PubMed ID: 37898760 [TBL] [Abstract][Full Text] [Related]
5. Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer's disease. Hellwig K; Kvartsberg H; Portelius E; Andreasson U; Oberstein TJ; Lewczuk P; Blennow K; Kornhuber J; Maler JM; Zetterberg H; Spitzer P Alzheimers Res Ther; 2015 Dec; 7():74. PubMed ID: 26698298 [TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal Fluid Concentration of Neurogranin in Hip Fracture Patients with Delirium. Halaas NB; Zetterberg H; Idland AV; Knapskog AB; Watne LO; Blennow K J Alzheimers Dis; 2021; 81(2):667-677. PubMed ID: 33814433 [TBL] [Abstract][Full Text] [Related]
13. Neurogranin and VILIP-1 as Molecular Indicators of Neurodegeneration in Alzheimer's Disease: A Systematic Review and Meta-Analysis. Dulewicz M; Kulczyńska-Przybik A; Mroczko B Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33172069 [TBL] [Abstract][Full Text] [Related]
14. The synaptic marker neurogranin as a disease state biomarker in Alzheimer's disease: a systematic review and meta-analysis. Wang Z; Yang J; Zhu W; Tang Y; Jia J Int J Neurosci; 2022 Dec; 132(12):1245-1253. PubMed ID: 33527855 [No Abstract] [Full Text] [Related]
15. Cerebrospinal fluid catecholamines in Alzheimer's disease patients with and without biological disease. Henjum K; Watne LO; Godang K; Halaas NB; Eldholm RS; Blennow K; Zetterberg H; Saltvedt I; Bollerslev J; Knapskog AB Transl Psychiatry; 2022 Apr; 12(1):151. PubMed ID: 35397615 [TBL] [Abstract][Full Text] [Related]
16. A meta-analysis on CSF neurogranin levels for the diagnosis of Alzheimer's disease and mild cognitive impairment. Mavroudis IA; Petridis F; Chatzikonstantinou S; Kazis D Aging Clin Exp Res; 2020 Sep; 32(9):1639-1646. PubMed ID: 31463927 [TBL] [Abstract][Full Text] [Related]
17. The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer's Disease. De Vos A; Struyfs H; Jacobs D; Fransen E; Klewansky T; De Roeck E; Robberecht C; Van Broeckhoven C; Duyckaerts C; Engelborghs S; Vanmechelen E J Alzheimers Dis; 2016 Jul; 53(4):1523-38. PubMed ID: 27392859 [TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal Fluid YKL-40 and Neurogranin in Familial Alzheimer's Disease: A Pilot Study. Thordardottir S; Almkvist O; Johansson C; Zetterberg H; Blennow K; Graff C J Alzheimers Dis; 2020; 76(3):941-953. PubMed ID: 32568193 [TBL] [Abstract][Full Text] [Related]